Chemaxon, a leader in cheminformatics software development for life science research, announced the appointment of Richard Jones as Chief Executive Officer (CEO). Richard follows owner Ferenc (Csizi) Csizmadia in the position.
“Chemaxon has a great reputation globally. Following on from my work in Lab of the Future, I am excited about the opportunity to take data in science and technology and use it to do amazing things, together with our expert team and our expanding range of users. We have great plans for the coming years, and we will be reaching out to our customers shortly to share with them.” Comments Richard Jones, new CEO of Chemaxon.
Chemaxon’s founder and outgoing CEO, Ferenc “Csizi” Csizmadia, steps down after almost 7 years at the helm of the company he founded 24 years ago.“We have worked closely with Richard to align strategy and culture, in order to ensure Chemaxon’s continued success. I have all confidence in his ability to take the company further, and look forward to seeing the company grow and flourish under his leadership." Csizi keeps his role as Founder and moves on to found Ancestralize, focusing on health and well-being in the digital age.
The appointment coincides with Chemaxon Budapest offices moving to Váci Greens, a newly built eco-conscious office park on the eastern side of the Danube.
Chemaxon.com 2022.02.01
Related content
Certara Completes Acquisition of Chemaxon
The combined organization offers life sciences companies predictive biosimulation and scientific...
Certara to Acquire Chemaxon to Strengthen Drug Discovery Software Portfolio
We are excited to share the official announcement of Certara, our partner for over a decade, as...
Roadblocks of DMTA project success - and how to eliminate them
Discover how to navigate complex challenges in your DMTA projects - make informed compound...
"Make the company look like I won the lottery"
This article was originally published in Hungarian, in November 2023. Visit Publication Chemaxon...